Fifty 1 Labs Stock Price, News & Analysis

FITY OTC Link

Company Description

Welcome to the overview page for Fifty 1 Labs (FITY), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

Chart

$0.0033

0.00%

0.00

Last updated: August 2, 2025 at 15:22

- %

Performance 1 year

$1.5M

Market Cap

616.9M

Shares outstanding

Latest News

View All

3 days ago

21.43%

Fifty 1 Labs, Inc. Hosts Successful Virtual Shareholder Teleconference, Showcasing AI-Driven Functional Medicine Strategy and World-Class Leadership

4 days ago

0.00%

Fifty 1 Labs, Inc. to Host Virtual Shareholder Teleconference Featuring World-Class Leadership Team, including Dr. James Orbinski, who received the Nobel Peace Prize on Behalf of Médecins Sans Frontières

management conferences

15 days ago

10.42%

Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies

partnership acquisition AI

22 days ago

18.37%

Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership

clinical trial covid-19 AI

24 days ago

31.82%

Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment

April 30, 2025

2.00%

Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness

partnership management dividends +1

SEC Filings

View All

No SEC filings available for Fifty 1 Labs.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

January 1, 2026 - March 31, 2026

OTCQB uplisting

Company plans to uplist to OTCQB by end of Q1 2026

January 1, 2026 - March 31, 2026

OTCQB uplisting

Target uplisting from OTC to OTCQB by Q1 2026

January 1, 2026 - March 31, 2026

Uplist to OTCQB

Scheduled uplisting to OTCQB by Q1 2026

July 1, 2027

Biotech acquisition deadline

Planned $5-10M biotech acquisition to complete by July 2027

Frequently Asked Questions

What is the current stock price of Fifty 1 Labs (FITY)?

The current stock price of Fifty 1 Labs (FITY) is $0.0033 as of August 1, 2025.

What is the market cap of Fifty 1 Labs (FITY)?

The market cap of Fifty 1 Labs (FITY) is approximately 1.5M.